First-episode psychosis in a 15 year-old female with clinical presentation of anti-NMDA receptor encephalitis: A case report and review of the literature

被引:7
作者
Moura M. [1 ,2 ]
Silva-Dos-Santos A. [2 ,3 ,4 ]
Afonso J. [5 ]
Talina M. [2 ,6 ]
机构
[1] Unit of Child and Adolescent Psychiatry, Department of Psychiatry, Hospital Vila Franca de Xira, R. do Parque Res. dos Povos 1, Vila Franca de Xira
[2] Department of Psychiatry, Hospital Vila Franca de Xira, R. do Parque Res. dos Povos 1, Vila Franca de Xira
[3] Faculty of Medicine, Institute of Pharmacology and Neurosciences, University of Lisbon, Lisbon
[4] Unit of Neurosciences, Institute of Molecular Medicine, University of Lisbon, Av. Professor Egas Moniz, Lisbon
[5] Child and Adolescent Psychiatry Unit, Hospital Dona Estefânia-Centro Hospitalar de Lisboa Central, R. Jacinta Marto, Lisbon
[6] CEDOC, Chronic Diseases Research Centre, Nova Medical School, Faculdade de Ciencias Médicas, New University of Lisbon, Campo Mártires da Pátria 130, Lisbon
关键词
Adolescent; Anti-NMDA receptor encephalitis; Case report; First-episode psychosis; Psychosis;
D O I
10.1186/s13104-016-2180-6
中图分类号
学科分类号
摘要
Background: Anti-NMDA receptor encephalitis is an autoimmune disease that was identified in 2007, and manifests in a stepwise manner with psychiatric, neurological and autonomic symptoms. The disease is caused by autoantibodies against NMDA receptors. It can have a paraneoplastic origin, mainly secondary to ovarian teratomas, but it can also be unrelated to the tumor. This disease can affect both sexes and all ages. Case presentation: Here, we present a case of a 15 year-old female adolescent with first-episode psychosis with anti-NMDA receptor encephalitis not related to tumor, which manifested with delusion, hallucinations, panic attacks, agitation, and neurological symptoms, and later with autonomic instability. She was treated with immunotherapy and psychiatric medication resulting in improvement of her main psychiatric and neurological symptoms. Conclusion: Our main objective in presenting this case is to alert clinicians to this challenging and recent disease that has a clinical presentation that might resemble a functional psychiatric condition and can be underdiagnosed in the context of child and adolescent psychiatry. © 2016 The Author(s).
引用
收藏
相关论文
共 27 条
[1]  
Kayser M.S., Kohler C.G., Dalmau J., Psychiatric manifestations of paraneoplastic disorders, Am J Psychiatry, 167, 9, pp. 1039-1050, (2010)
[2]  
Nokura K., Yamamoto H., Okawara Y., Koga H., Osawa H., Sakai K., Reversible limbic encephalitis caused by ovarian teratoma, Acta Neurol Scand, 95, 6, pp. 367-373, (1997)
[3]  
Vitaliani R., Mason W., Ances B., Zwerdling T., Jiang Z., Dalmau J., Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma, Ann Neurol, 58, 4, pp. 594-604, (2005)
[4]  
Aydiner A., Gurvit H., Baral I., Paraneoplastic limbic encephalitis with immature ovarian teratoma - A case report, J Neurooncol, 37, 1, pp. 63-66, (1998)
[5]  
Lee A.C., Ou Y., Lee W.K., Wong Y.C., Paraneoplastic limbic encephalitis masquerading as chronic behavioural disturbance in an adolescent girl, Acta Paediatr, 92, 4, pp. 506-509, (2003)
[6]  
Stein-Wexler R., Wootton-Gorges S.L., Greco C.M., Brunberg J.A., Paraneoplastic limbic encephalitis in a teenage girl with an immature ovarian teratoma, Pediatr Radiol, 35, 7, pp. 694-697, (2005)
[7]  
Dalmau J., Tuzun E., Wu H.Y., Masjuan J., Rossi J.E., Voloschin A., Baehring J.M., Shimazaki H., Koide R., King D., Et al., Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma, Ann Neurol, 61, 1, pp. 25-36, (2007)
[8]  
Cahalan S., Brain on Fire: My Month of Madness, (2012)
[9]  
Kayser M.S., Dalmau J., Anti-NMDA receptor encephalitis in psychiatry, Current Psychiatry Rev, 7, 3, pp. 189-193, (2011)
[10]  
Dalmau J., Gleichman A.J., Hughes E.G., Rossi J.E., Peng X., Lai M., Dessain S.K., Rosenfeld M.R., Balice-Gordon R., Lynch D.R., Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies, Lancet Neurol, 7, 12, pp. 1091-1098, (2008)